Characterization of Chronic Hepatitis B Cases Among Foreign-Born Persons in Six Population-Based Surveillance Sites, United States 2001–2010

Journal of Immigrant and Minority Health

Volumn 17, Issue 1, 2015, Pages 7-12

  Liu, Stephen J ^a,f   Iqbal, Kashif ^a   Shallow, Sue ^b   Speers, Suzanne ^c   Rizzo, Elena ^d   Gerard, Kristin ^c   Poissant, Tasha ^e   Klevens, R Monina ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^c Connecticut Department of Public Health ^*  (United States)

^d NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^e OREGON HEALTH AUTHORITY   (United States)

^f NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Birth country; Chinese born; HBsAg prevalence; Perinatal transmission; Provider screening

Indexed keywords

ADOLESCENT; ADULT; FEMALE; HEALTH SURVEY; HEPATITIS B, CHRONIC; HUMAN; MALE; MIDDLE AGED; MIGRANT; PREVALENCE; UNITED STATES;

ADOLESCENT; ADULT; EMIGRANTS AND IMMIGRANTS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; UNITED STATES;

EID: 84897355975     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-014-0012-0     Document Type: Article

References (24)

1. Ganem D, Prince AM. Hepatitis B virus infection: natural history and clinical consequences. N Engl J Med. 2004;350(11):1118–29.
2. Alter MJ. Epidemiology and prevention of hepatitis B. Semin Liver Dis. 2003;23(1):39–46.
3. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR-16):1–31.
4. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212–9.
5. Wasley A, Kruszon-Moran D, Kuhnert W, Simard E, Finelli L, McQuillan G, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202(2):192–201.
6. IOM. Hepatitis and liver cancer information for health care providers. Washington: National Academy of Sciences, Institute of Medicine; 2010.
7. Kowdley KV, Wang CC, Welch S, et al. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 2012;56(2):422–33.
8. France AM, Bornschlegel K, Lazaroff J, et al. Estimating the prevalence of chronic hepatitis B virus infection-New York City, 2008. J Urban Health. 2012;89:373–83.
9. CDC. Characteristics of persons with chronic hepatitis B: San Francisco, California, 2006. Morb Mortal Wkly Rep. 2007;56(18):446–8.
10. Weinbaum C, Williams I, Mast E, Wang S, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1–20.
11. Hoffman RE, Greenblatt J, Matyas BT, Sharp DJ, Esteban E, Hodge K, et al. Capacity of state and territorial health agencies to prevent foodborne illness. Emerg Infect Dis. 2005;11(1):11–6.
12. CDC. EIP Sites, In: Division of Preparedness and Emerging Infections. 2011. http://www.cdc.gov/ncezid/dpei/eip/eip-sites.html.
13. US Census. In: Census data. United States Census Bureau. 2010.
14. CDC. Case definitions. Chronic hepatitis B virus 2011. CDC: Atlanta; 2011.
15. CDC. Prevention of perinatal hepatitis B through enhanced case management–Connecticut, 1994–95, the United States, 1994. Morb Mortal Wkly Rep. 1996;45(27):584–7.
16. Din ES, Wasley A, Jacques-Carroll L, et al. Estimating the number of births to hepatitis B virus-infected women in 22 states, 2006. Pediatr Infect Dis J. 2011;30(7):575–9.
17. US Department of Homeland Security. 2010 Yearbook of Immigration Statistics. In: US Department of Homeland Security: Office of Immigration Statistics; 2011.
18. Liu SJ, Klevens RM, Iqbal K, Speers S, Rizzo E, Shallow S, et al. Evaluation of data quality improvement of chronic hepatitis B surveillance in EIP sites. In. APHA Annual Meeting; 2011.
19. Centers for Disease Control and Prevention. Surveillance for chronic hepatitis B virus infection: New York City, June 2008–November 2009. Morb Mortal Wkly Rep. 2012;61(1):6–9.
20. Klevens RM, Liu S, Roberts H, Jiles RB, Holmberg SD. Estimating acute viral hepatitis infections from nationally reported cases. Am J Public Health. 2014;104(3):482–7.
21. Derose KP, Bahney BW, Lurie N, et al. Review: immigrants and health care access, quality, and cost. Med Care Res Rev. 2009;66(4):355–408.
22. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507–39.
23. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–2.
24. Sung JJ, Tsoi KK, Wong VW, et al. Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma. Aliment Pharmacol Ther. 2008;28(9):1067–77.